Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: The CRISP AMI randomized trial

JAMA

Volumn 306, Issue 12, 2011, Pages 1329-1337

  Patel, Manesh R ^a   Smalling, Richard W ^c   Thiele, Holger ^d   Barnhart, Huiman X ^b   Zhou, Yi ^a   Chandra, Praveen ^e   Chew, Derek ^f   Cohen, Marc ^g   French, John ^h   Perera, Divaka ⁱ   Ohman, E Magnus ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e MEDANTA THE MEDICITY   (India)

^f FLINDERS MEDICAL CENTRE   (Australia)

^g NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^h LIVERPOOL HOSPITAL   (Australia)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANTERIOR MYOCARDIAL INFARCTION; AORTA BALLOON; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; COUNTERPULSATION; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE MASS; HIGH RISK PATIENT; HUMAN; INTRAAORTIC BALLOON COUNTERPULSATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOLYSIS IN MYOCARDIAL INFARCTION FLOW SCORE; TRANSFUSION; VASCULAR DISEASE;

EID: 80053194306     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1280     Document Type: Article

References (30)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13-20. (Pubitemid 36050955)
2. Antman EM, Anbe DT, Armstrong PW, et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task ForceonPractice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110(5):588-636. (Pubitemid 39036178)
3. Flynn A, Moscucci M, Share D, et al. Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Arch Intern Med. 2010;170 (20):1842-1849.
4. Wang TY, Fonarow GC, Hernandez AF, et al.The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes. Arch InternMed. 2009;169(15):1411-1419.
5. Lloyd-Jones D, Adams R, Carnethon M, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2009 update:are port from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):480-486.
6. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002;105(5):656-662. (Pubitemid 34123444)
7. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation.1996; 93(2):223-228. (Pubitemid 26031478)
8. Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94(6):730-736. (Pubitemid 351744690)
9. Ezekowitz JA, Armstrong PW, Granger CB, et al. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) substudy. Am Heart J. 2010; 160(2):272-278.
10. Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intraaortic balloon pumping in patients after coronary angioplasty. Circulation. 1993;87(2):500-511. (Pubitemid 23040920)
11. Williams DO, Korr KS, Gewirtz H, Most AS.The effect of intraaortic balloon counterpulsation on regional myocardialblood flow and oxygen consumption in the presence of coronary artery stenosis in patientswith unstable angina. Circulation. 1982;66(3):593-597.
12. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock?JAm Coll Cardiol. 2000;36(3)(suppl A):1123-1129.
13. Hochman JS, Sleeper LA, White HD, et al SHOCK Investigators (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock).One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285(2):190-192.
14. Stone GW, Marsalese D, Brodie BR, et al Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 1997; 29(7):1459-1467. (Pubitemid 27272437)
15. Brodie BR, Stuckey TD, Hansen C, Muncy D. Intraaortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol. 1999; 84(1):18-23. (Pubitemid 29307635)
16. Cohen M, Urban P, Christenson JT, et al Benchmark Registry Collaborators. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J. 2003;24(19):1763-1770. (Pubitemid 37236866)
17. Achour H, Boccalandro F, Felli P, et al. Mechanical left ventricular unloading prior to reperfusion reduces infarct size in a canine infarction model. Catheter Cardiovasc Interv. 2005;64(2):182-192. (Pubitemid 40189186)
18. LeDouxJF, Tamareille S, Felli PR, Amirian J, Smalling RW. Left ventricular unloading with intra-aortic counter pulsation prior to reperfusion reduces myocardial release of endothelin-1 and decreases infarction size in a porcine ischemia-reperfusion model. Catheter Cardiovasc Interv. 2008;72(4):513-521.
19. Azevedo CF, Amado LC, Kraitchman DL, et al. The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. Eur Heart J. 2005;26(12):1235-1241. (Pubitemid 40863131)
20. Patel MR,Thiele H, Smalling RW, et al. A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial. Am Heart J. 2011;162(1):47-55, e1.
21. Thiele H, Kappl MJE, Conradi S, Niebauer J, Hambrecht R, Schuler G. Reproducibility of chronic and acute infarctsize measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol. 2006;47(8): 1641-1645.
22. Patel MR, Worthley SG, Stebbins A,et al.Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a delayed enhancement cardiac magnetic resonance substudy from theAPEX-AMItrial.JACC Cardiovasc Imaging. 2010;3(1):52-60.
23. Kim RJ, Albert TS, Wible JH, et al Gadoversetamide Myocardial Infarction Imaging Investigators. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008;117(5):629-637.
24. Stone GW, Dixon SR, Grines CL, et al. Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol. 2007;100(9): 1370-1375. (Pubitemid 47592901)
25. O'Neill WW, Martin JL, Dixon SR, et al AMIHOT Investigators. Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention. J Am Coll Cardiol. 2007; 50(5):397-405. (Pubitemid 47088128)
26. Thiele H, Schindler K, Friedenberger J, et al. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarctionundergoingprimary percutaneous coronary intervention: the randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction trial. Circulation.2008; 118(1): 49-57.
27. Francone M, Bucciarelli-Ducci C, CarboneI, et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54(23):2145-2153.
28. Eitel I, Desch S, Fuernau G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol. 2010;55 (22):2470-2479.
29. Bonnefoy E, Steg PG, Boutitie F, et al CAPTIM Investigators. Comparison of Primary Angioplasty and Pre-Hospital Fibrinolysis in Acute Myocardial Infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J. 2009; 30(13):1598-1606.
30. Perera D, Stables R, Thomas M, et al; BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010;304(8): 867-874.